Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PhyNexus

PhyNexus
2002 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of automated lab-scale purification technology of biomolecules for pharmaceutical, research, drug screening and lead optimization, drug development, clinical trials, and other industries. The company provides automation platform based on dual flow chromatography and patented tip technology for high throughput purification of biomolecules such as proteins, plasmids, and antibodies and offer protein and plasmid sample preparation columns and robotics for diagnostic, protein purification, chromatin immunoprecipitation, immunogenicity, and protein analytics applications.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Electronic Equipment and Instruments
Other Industries
Automation/Workflow Software
Parent Company
Primary Office
  • 3670 Charter Park Drive
  • Suite A
  • San Jose, CA 95136
  • United States

+1 (408) 000-0000

PhyNexus Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore PhyNexus‘s full profile, request access.

Request full access to PitchBook

PhyNexus Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 00000000 Corporation Malaga, Australia
To view this company’s complete list of competitors, request access »

PhyNexus Executive Team (2)

Name Title Board
Seat
Contact
Info
Douglas Gjerde Ph.D Founder, Director & Chief Executive Officer
Tiffany Nguyen JD President